Table 3.
Distribution of first prescription claimed for glucose-lowering medications according to year of first-time myocardial infarction.
| 1997-1998 | 1999-2000 | 2001-2002 | 2003-2004 | 2005-2006 | p for trend. | |
|---|---|---|---|---|---|---|
| Metformin (%) | 30.47 | 33.83 | 36.62 | 38.03 | 39.94 | <0.0001 |
| Insulin (%) | 9.07 | 9.59 | 12.70 | 13.25 | 14.29 | 0.002 |
| Sulfonylurea (%) | 59.07 | 55.43 | 48.90 | 48.01 | 45.48 | <0.0001 |
| Other GLM(%)a | 1.38 | 1.16 | 1.78 | 0.71 | 0.29 | 0.15 |
a GLM: glucose-lowering medications: Other GLM: glitazones, acarbose, repaglinide, and repaglinide + metformin.